These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 29603410)

  • 41. Peanut oral immunotherapy in a pediatric allergy clinic: Patient factors associated with clinical outcomes.
    Guarnieri KM; Slack IF; Gadoury-Lévesque V; Eapen AA; Andorf S; Lierl MB
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):214-222.e4. PubMed ID: 33839246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
    Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
    J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peanut oral immunotherapy using an extensively heated and baked novel composition of peanuts.
    Kidon MI; Shavit R; Levy Y; Haj Yahia S; Machnes-Maayan D; Frizinsky S; Maoz-Segal R; Offenganden I; Kenett RS; Nancy AL; Hovav R
    Pediatr Allergy Immunol; 2024 May; 35(5):e14146. PubMed ID: 38783409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peanut Oral Immunotherapy With or Without H
    Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current Trend in Immunotherapy for Peanut Allergy.
    Joo Chan C; Richardo T; Lim RLH
    Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on peanut allergy: Prevention and immunotherapy.
    Cook QS; Kim EH
    Allergy Asthma Proc; 2019 Jan; 40(1):14-20. PubMed ID: 30582491
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
    Scurlock AM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind placebo-controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation.
    Kukkonen AK; Uotila R; Malmberg LP; Pelkonen AS; Mäkelä MJ
    Acta Paediatr; 2017 Feb; 106(2):274-281. PubMed ID: 27859599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial.
    Yu GP; Weldon B; Neale-May S; Nadeau KC
    Int Arch Allergy Immunol; 2012; 159(2):179-82. PubMed ID: 22678151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.
    Anagnostou K; Islam S; King Y; Foley L; Pasea L; Bond S; Palmer C; Deighton J; Ewan P; Clark A
    Lancet; 2014 Apr; 383(9925):1297-1304. PubMed ID: 24485709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and Efficacy of Low-Dose Oral Immunotherapy for Hen's Egg Allergy in Children.
    Yanagida N; Sato S; Asaumi T; Nagakura K; Ogura K; Ebisawa M
    Int Arch Allergy Immunol; 2016; 171(3-4):265-268. PubMed ID: 28049193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
    Jones SM; Kim EH; Nadeau KC; Nowak-Wegrzyn A; Wood RA; Sampson HA; Scurlock AM; Chinthrajah S; Wang J; Pesek RD; Sindher SB; Kulis M; Johnson J; Spain K; Babineau DC; Chin H; Laurienzo-Panza J; Yan R; Larson D; Qin T; Whitehouse D; Sever ML; Sanda S; Plaut M; Wheatley LM; Burks AW;
    Lancet; 2022 Jan; 399(10322):359-371. PubMed ID: 35065784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
    Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
    J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis.
    Gamazo C; García-Azpíroz M; Souza Rebouças J; Gastaminza G; Ferrer M; Irache JM
    Immunotherapy; 2017 Nov; 9(15):1205-1217. PubMed ID: 29130802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy.
    Wright BL; Fernandez-Becker NQ; Kambham N; Purington N; Tupa D; Zhang W; Rank MA; Kita H; Shim KP; Bunning BJ; Doyle AD; Jacobsen EA; Boyd SD; Tsai M; Maecker H; Manohar M; Galli SJ; Nadeau KC; Chinthrajah RS
    Front Immunol; 2018; 9():2624. PubMed ID: 30524424
    [No Abstract]   [Full Text] [Related]  

  • 56. Early sustained unresponsiveness after short-course egg oral immunotherapy: a randomized controlled study in egg-allergic children.
    Escudero C; Rodríguez Del Río P; Sánchez-García S; Pérez-Rangel I; Pérez-Farinós N; García-Fernández C; Ibáñez MD
    Clin Exp Allergy; 2015 Dec; 45(12):1833-43. PubMed ID: 26236997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children.
    Kulis M; Yue X; Guo R; Zhang H; Orgel K; Ye P; Li Q; Liu Y; Kim E; Burks AW; Vickery BP
    Clin Exp Allergy; 2019 Feb; 49(2):180-189. PubMed ID: 30126028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open-label, single-arm trial.
    Grzeskowiak LE; Tao B; Aliakbari K; Chegeni N; Morris S; Chataway T
    Clin Exp Allergy; 2023 Mar; 53(3):327-336. PubMed ID: 36628520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy.
    Chen G; Shrock EL; Li MZ; Spergel JM; Nadeau KC; Pongracic JA; Umetsu DT; Rachid R; MacGinnitie AJ; Phipatanakul W; Schneider L; Oettgen HC; Elledge SJ
    Cell Rep Med; 2021 Oct; 2(10):100410. PubMed ID: 34755130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.
    Varshney P; Jones SM; Scurlock AM; Perry TT; Kemper A; Steele P; Hiegel A; Kamilaris J; Carlisle S; Yue X; Kulis M; Pons L; Vickery B; Burks AW
    J Allergy Clin Immunol; 2011 Mar; 127(3):654-60. PubMed ID: 21377034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.